Andrew Tym Hattersley
Hattersley, Andrew T.
Hattersley, Andrew
VIAF ID: 315223483 (Personal)
Permalink: http://viaf.org/viaf/315223483
Preferred Forms
-
100 0 _
‡a
Andrew Tym Hattersley
-
100 1 _ ‡a Hattersley, Andrew
-
100 1 _ ‡a Hattersley, Andrew T.
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Genetyka molekularna wkracza do kliniki cukrzycy : program edukacyjny : diabetologia |
|
| Niske doze sulfonilureje kao uspješna zamjena za inzulin u liječenju neonatalnog dijabetesa uzrokovanog aktivirajućom mutacijom KIR6.2. |
|
| Prediction algorithms: pitfalls in interpreting genetic variants of autosomal dominant monogenic diabetes |
|
| Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation |
|
| Prematurity and Genetic Testing for Neonatal Diabetes. |
|
| Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth |
|
| The prevalence of monogenic diabetes in Australia: the Fremantle Diabetes Study Phase II. |
|
| Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia |
|
| The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY. |
|
| Prime suspect: the TCF7L2 gene and type 2 diabetes risk |
|
| A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape |
|
| Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study |
|
| Proposed mechanism for a novel insertion/deletion frameshift mutation (I414G415ATCG?CCA) in the hepatocyte nuclear factor 1 alpha (HNF-1?) gene which causes maturity-onset diabetes of the young (MODY) |
|
| Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution |
|
| Psychiatric morbidity in children with KCNJ11 neonatal diabetes. |
|
| Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. |
|
| A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations |
|
| Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic. |
|
| Rapid and sensitive real-time polymerase chain reaction method for detection and quantification of 3243A>G mitochondrial point mutation |
|
| Rare and low-frequency coding variants alter human adult height |
|
| Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. |
|
| Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis |
|
| Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia |
|
| Recessively Inherited LRBA Mutations Cause Autoimmunity Presenting as Neonatal Diabetes |
|
| Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation |
|
| Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study |
|
| Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age. |
|
| A reference panel of 64,976 haplotypes for genotype imputation |
|
| Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. |
|
| Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels |
|
| Regulation of Fto/Ftm gene expression in mice and humans |
|
| Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes |
|
| Reported parental age of death in type 2 diabetic patients with and without established diabetic nephropathy |
|
| Response to comment on: Besser et al. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care 2013;36:195-201. |
|
| Response to Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834 |
|
| Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene |
|
| Rfx6 directs islet formation and insulin production in mice and humans |
|
| Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study |
|
| The role of genetic susceptibility in diabetic nephropathy: evidence from family studies |
|
| The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy |
|
| The role of the HNF4α enhancer in type 2 diabetes |
|
| sabbu |
|
| Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study |
|
| Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement. |
|
| Sequence data and association statistics from 12,940 type 2 diabetes cases and controls |
|
| Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data |
|
| Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c? |
|
| SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion |
|
| Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations |
|
| South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European people |
|
| Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide |
|
| Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases |
|
| A study of association between common variation in the growth hormone-chorionic somatomammotropin hormone gene cluster and adult fasting insulin in a UK Caucasian population |
|
| Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. |
|
| Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations |
|
| Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. |
|
| Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017 |
|
| Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017 |
|
| Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect |
|
| Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans |
|
| Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated |
|
| tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humans |
|
| Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020 |
|
| Type 2 diabetes risk alleles are associated with reduced size at birth |
|
| Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion |
|
| Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals |
|
| Type II diabetes: search for primary defects |
|
| A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin |
|
| Underlying genetic models of inheritance in established type 2 diabetes associations |
|
| Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency? |
|
| Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative review |
|
| Unlocking the secrets of the pancreatic beta cell: man and mouse provide the key. |
|
| Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes |
|
| Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study |
|
| Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes. |
|
| Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies |
|
| Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetes |
|
| Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis |
|
| The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation |
|
| Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight |
|
| Variants in the aromatase gene and on the Y-chromosome are not associated with adult height or insulin resistance in a UK population |
|
| Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study |
|
| Variation in the calpain-10 gene affects blood glucose levels in the British population |
|
| Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome |
|
| What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study |
|
| Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families |
|
| Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11. |
|
| Zinc Transporter 8 Autoantibodies (ZnT8A) and a Type 1 Diabetes Genetic Risk Score Can Exclude Individuals With Type 1 Diabetes From Inappropriate Genetic Testing for Monogenic Diabetes |
|
